Middle East and Africa Molecular Cytogenetics Market Report

Middle East and Africa Molecular Cytogenetics Market Size

The Middle East and Africa molecular cytogenetics market size was valued at USD 147.96 million in 2025 and is anticipated to reach USD 162.35 million in 2026 from USD 340.41 million by 2034, growing at a CAGR of 9.70% during the forecast period from 2026 to 2034.

Molecular biology and cytogenetics are the two primary fields that are studied under molecular cytogenetics. The study of chromosomes is termed Cytogenetics. Molecular cytogenetics further delves into the analysis of genetic variations and/or alterations through in-situ hybridization techniques.

The CGH technology category commands the largest market share of approximately 53% and is estimated to retain its leading position over the aforementioned forecast period. Rising awareness levels regarding the CGH techniques in molecular biology are likely to raise patient acceptance and widen the application horizon in molecular diagnostics. Also, effective cancer diagnosis because of novel diagnostic biomarkers' characterization coupled with the development of high-resolution, genetic testing platforms that diagnose constitutional and acquired diseases is vital to this market segment's growth.

The rising number of applications regarding the detection of complex chromosomal arrangements using multicolor FISH techniques and SNP-array analysis is another contributing factor for the growth of this segment.

Rising cases of various types of cancer coupled with the rising demand for high-throughput diagnostic tools are expected to boost the molecular cytogenetic technologies' usage rate over the aforementioned forecast period. The personalized medicine segment is poised to widen the therapeutic horizons in delivering enhanced, molecularly guided therapies and precise monitoring of disease progression, thereby leading to this market segment's growth.

It is geographically the last in terms of market share, and the UAE is the leading country in this region. It commands a market share of 6%.

KEY MARKET PLAYERS

Companies playing a leading role in the MEA Molecular Cytogenetics Market include

• Affymetrix, Inc.
• Agilent Technologies, Inc.
• Illumina, Inc.
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Applied Spectral Imaging, Inc.
• Thermo Fisher Scientific

MARKET SEGMENTATION

This research report on the Middle East and Africa Molecular Cytogenetics Market has been segmented and sub-segmented into the following categories:

By Product

• Kits & Reagents
  • Testing Kits
  • Probes
  • Fluorescent Affinity Reagents
  • Other Kits & Reagents
• Instruments
• Consumables
• Software & Services

By Technique:

• Comparative Genomic Hybridization
  • Array-Based Comparative Genomic Hybridization
  • Standard Comparative Genomic Hybridization
• Fluorescence in Situ Hybridization
• In Situ Hybridization
• Others

By Application

• Genetic Disorders
• Cancer
• Personalized Medicine
• Other Applications

By End User

• Clinical & Research Laboratories
• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

By Country

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA